Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Accumulated Expenses (2022 - 2023)

Silo Pharma (SILO) has disclosed Accumulated Expenses for 2 consecutive years, with $5891.0 as the latest value for Q4 2023.

  • Quarterly Accumulated Expenses fell 95.9% to $5891.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $5891.0 through Dec 2023, down 95.9% year-over-year, with the annual reading at $5891.0 for FY2023, 95.9% down from the prior year.
  • Accumulated Expenses hit $5891.0 in Q4 2023 for Silo Pharma, down from $20134.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $143607.0 in Q4 2022 to a low of $5891.0 in Q4 2023.